Monday 24 July 2017

Global Electric Dental Handpieces Sales Market- Production, Revenue, Price, Market Share and Growth Rate: Radiant Insights

In this report, the global Electric Dental Handpieces market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.In this report, the global Electric Dental Handpieces market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Electric Dental Handpieces for these regions, from 2012 to 2022 (forecast), covering
• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Download Full Research Report of Global Electric Dental Handpieces Sales Market @ http://www.radiantinsights.com/research/global-electric-dental-handpieces-sales-market-report-2017

Global Electric Dental Handpieces market competition by top manufacturers/players, with Electric Dental Handpieces sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Kavo

• NSK

• Dentsply Sirona

• W&H

• Bien Air

• MORITA

• DentalEZ

• Osada

• SciCan

• Anthogyr

• Codent

• Modeer Precision

• TTBIO

• Sinol

Request a Free Sample Copy of this Report @ http://www.radiantinsights.com/research/global-electric-dental-handpieces-sales-market-report-2017/request-sample

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• High-speed Dental Handpiece

• Low-speed Dental Handpiece

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Electric Dental Handpieces for each application, including

• Hospital

• Dental Clinic

• Other

Tuesday 18 July 2017

Global Blood Collection Tubes Sales Market Report, 2017 by Radiant Insights

In this report, the global Blood Collection Tubes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.In this report, the global Blood Collection Tubes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Blood Collection Tubes for these regions, from 2012 to 2022 (forecast), covering
• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Download Full Research Report of Blood Collection Tubes Sales Market @ http://www.radiantinsights.com/research/global-blood-collection-tubes-sales-market-report-2017

Global Blood Collection Tubes market competition by top manufacturers/players, with Blood Collection Tubes sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
• Becton Dickinson
• Immucor
• Sarstedt
• Greiner Group
• QIAGEN N.V.
• Terumo Corporation
• FL Medical
• Haemonetics
• Beckman Coulter
• AdvaCare Pharmaceuticals

Request a Free Sample Copy of this Report @ http://www.radiantinsights.com/research/global-blood-collection-tubes-sales-market-report-2017/request-sample

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
• Glass Tube
• Plastic Pipe

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Blood Collection Tubes for each application, including
• Hospital
• Clinic
• Other

About Radiant Insights, Inc

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake.

For more information or any query mail at sales@radiantinsights.com      

Monday 17 July 2017

Castration Resistant Prostate Cancer Treatment Market will grow at a CAGR of 9.01% till 2021|Radiant Insights

Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Astellas Pharma
• Johnson & Johnson
• Sanofi
• Valeant

Other prominent vendors
• Active Biotech
• Advaxis
• ANI Pharmaceuticals
• Athenex
• Bavarian Nordic
• Bayer
• Bristol-Myers Squibb
• CureVac
• GlaxoSmithKline
• Innocrin Pharmaceutical
• Merck
• Myovant Sciences
• Northwest Biotherapeutics
• OncoGenex Pharmaceuticals
• Oncolytics Biotech
• Orion
• Sotio
• Madrigal Pharmaceuticals)
• Takeda Pharmaceutical
• Teva Pharmaceutical Industries

Browse the Full Research Report of Castration Resistant Prostate Cancer Treatment Market till 2021 at - http://www.radiantinsights.com/research/global-castration-resistant-prostate-cancer-treatment-market-2017-2021

Prostate cancer is also known as carcinoma of the prostate is cancer of the prostate gland that affects only the male population. It is a slow progressive disease. CRPC is an inveterate stage of prostate cancer, in which almost 90% of individuals develop metastases, specifically in the skeleton. The major therapies involved in the treatment of CRPC are hormonal therapy and chemotherapy.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Market driver

• Physician's preference toward hormonal therapy
• For a full, detailed list, view our report

Market challenge
• High cost of treatment
• For a full, detailed list, view our report

Market trend
• Increasing consolidation in cancer treatment market
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Request a Free Sample Copy of this Report @ http://www.radiantinsights.com/research/global-castration-resistant-prostate-cancer-treatment-market-2017-2021/request-sample

Tuesday 4 July 2017

Histology and Cytology Market size will reach to USD 26.9 billion by 2025: Radiant Insights

The global histology and cytology market size is expected to reach USD 26.9 billion by 2025, according to a new report by Grand View Research, Inc. Globally, the increasing incidence of cancer and growing adoption of cytological tests due to its less invasive nature as compared to biopsy & higher reliability are likely to drive the market during the forecast period. Furthermore, rising well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect the market growth.

Advancements in the cytology and histology save the time for pathologists, hence this makes the service more cost-effective.Cytology was the largest segment in the histology and cytology market in 2016 and is expected to maintain its dominance during the forecast period due to the recent entry of various tests for cytological testing and advantages over histology such as faster analysis and economical technique.

Cytology is further segmented into cervical, breast, and other cancers based on its application. Cervical cancer segment dominated in 2016 due to higher incidence and growing demand of test for the cervical cancer screening. Furthermore, breast cancer was considered as the second largest segment due to rising awareness about breast cancer screening in emerging countries.

Download Full Research Report of Histology and Cytology Market @ http://www.radiantinsights.com/research/histology-and-cytology-market

Further key findings from the report suggest:
• Rising incidence of cancer and growing investment by players are expected to propel growth at the fastest rate with a CAGR of 13.5% from 2017 to 2025
• Cytology testing segment dominated in 2016 and is estimated to account for majority of the share by 2025.
• Cytological testing for cervix is the largest contributing segment of the market. This can be attributed to high incidence and more adoption of the test for cervix screening.
• The U.S. market was the largest in 2016 and is expected to maintain its dominance during forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries.
• In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves the detection of cervical precancer.
• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and increasing adoption of screening tests.
• Some of the key players operating are Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.

For free sample copy of this report, visit here: www.radiantinsights.com/research/histology-and-cytology-market/request-sample